Intelligence Platform
Patents
Browse 774 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 10709812
Biodegradable hydrogel for tissue expansion
granted patentUS 10709705
Aminopyrimidines as ALK inhibitors
granted patentUS 10676527
Methods and compositions for modulation of blood-neural barrier
granted patentUS 10677801
Diagnosis and treatment of breast cancer
granted patentUS 10669320
Mps1 and KNL1 phosphorylation system
granted patentUS 10662183
Inhibitors of myocardin-related transcription factor and serum response factor (MRTF/SRF)-
granted patentUS 10660895
Methods for treating amyotrophic lateral sclerosis
granted patentUS 10633344
Multiple-component solid phases containing at least one active pharmaceutical ingredient
granted patentUS 10633386
BET protein degraders
granted patentUS 10632209
ASH1L inhibitors and methods of treatment therewith
granted patentUS 10596245
Staphylococcus aureus materials and methods
granted patentUS 10590137
Mercaptopurine hemihydrate
granted patentUS 10590142
Deuterated amlexanox
granted patentUS 10588907
Methods and compositions for inhibiting the interaction of menin with MLL proteins
granted patentUS 10570401
Compositions and method for destabilizing, altering, and dispersing biofilms
granted patentUS 10568963
Multifunctional nanoplatforms for fluorescence imaging and photodynamic therapy developed
granted patentUS 10562975
CD6 antibody for treatment of T-cell mediated diseases or disorders
granted patentUS 10557850
Anti-CXCR1 compositions and methods
granted patentUS 10553318
Individual and cohort pharmacological phenotype prediction platform
granted patentUS 10543337
Nitric oxide delivery devices
granted patentUS 10513587
Self-integrating hydrogels and methods for making the same
granted patentUS 10512691
Systems and methods for targeted imaging and ablation of cardiac cells
granted patentUS 10512667
Compositions and methods for treating conditions related to adrenocortical activity and/or
granted patentUS 10508134
Peptide compositions and methods of use
granted